 | • レポートコード：MRC309Z7878 • 出版社/出版日：GlobalInfoResearch / 2023年9月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医薬品＆ヘルスケア |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界のヒトアルブミン注射の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界のヒトアルブミン注射市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - ヒトアルブミン注射の成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため ヒトアルブミン注射市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・採血、再結合 用途別セグメント ・病院、診療所 主要な市場プレーヤー ・Octapharma、CSL Behring、Biotest (UK) Ltd、Baxter、Kedrion Biopharma, Inc.、Grifols、GE HealthCare、Bio Products Laboratory、Green Cross、SK Plasma、Instituto Grifols、Takeda、Hualan Bio、Nanyue Biopharmaceuticals 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、ヒトアルブミン注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なヒトアルブミン注射メーカーの企業概要、2019年～2022年までのヒトアルブミン注射の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なヒトアルブミン注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別ヒトアルブミン注射の販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までのヒトアルブミン注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒトアルブミン注射市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、およびヒトアルブミン注射の産業チェーンを掲載しています。 ・第14、15章では、ヒトアルブミン注射の販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - ヒトアルブミン注射の概要 - 種類別分析（2018年vs2022年vs2029年）：採血、再結合 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所 - 世界のヒトアルブミン注射市場規模・予測 - 世界のヒトアルブミン注射生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Octapharma、CSL Behring、Biotest (UK) Ltd、Baxter、Kedrion Biopharma, Inc.、Grifols、GE HealthCare、Bio Products Laboratory、Green Cross、SK Plasma、Instituto Grifols、Takeda、Hualan Bio、Nanyue Biopharmaceuticals ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：採血、再結合 ・用途別分析2018年-2029年：病院、診療所 ・ヒトアルブミン注射の北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・ヒトアルブミン注射のヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・ヒトアルブミン注射のアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・ヒトアルブミン注射の南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・ヒトアルブミン注射の中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Human Albumin Injection market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Human albumin solutions are used in a range of medical and surgical problems.
This report is a detailed and comprehensive analysis for global Human Albumin Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Human Albumin Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Albumin Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Albumin Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Human Albumin Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Albumin Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Albumin Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Octapharma, CSL Behring, Biotest (UK) Ltd, Baxter and Kedrion Biopharma, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Human Albumin Injection market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Blood Extraction
Recombine
Market segment by Application
Hospital
Clinic
Major players covered
Octapharma
CSL Behring
Biotest (UK) Ltd
Baxter
Kedrion Biopharma, Inc.
Grifols
GE HealthCare
Bio Products Laboratory
Green Cross
SK Plasma
Instituto Grifols
Takeda
Hualan Bio
Nanyue Biopharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Albumin Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Albumin Injection, with price, sales, revenue and global market share of Human Albumin Injection from 2018 to 2023.
Chapter 3, the Human Albumin Injection competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Albumin Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Human Albumin Injection market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Albumin Injection.
Chapter 14 and 15, to describe Human Albumin Injection sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Human Albumin Injection
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Albumin Injection Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Blood Extraction
1.3.3 Recombine
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Albumin Injection Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Human Albumin Injection Market Size & Forecast
1.5.1 Global Human Albumin Injection Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Albumin Injection Sales Quantity (2018-2029)
1.5.3 Global Human Albumin Injection Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Octapharma
2.1.1 Octapharma Details
2.1.2 Octapharma Major Business
2.1.3 Octapharma Human Albumin Injection Product and Services
2.1.4 Octapharma Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Octapharma Recent Developments/Updates
2.2 CSL Behring
2.2.1 CSL Behring Details
2.2.2 CSL Behring Major Business
2.2.3 CSL Behring Human Albumin Injection Product and Services
2.2.4 CSL Behring Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CSL Behring Recent Developments/Updates
2.3 Biotest (UK) Ltd
2.3.1 Biotest (UK) Ltd Details
2.3.2 Biotest (UK) Ltd Major Business
2.3.3 Biotest (UK) Ltd Human Albumin Injection Product and Services
2.3.4 Biotest (UK) Ltd Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Biotest (UK) Ltd Recent Developments/Updates
2.4 Baxter
2.4.1 Baxter Details
2.4.2 Baxter Major Business
2.4.3 Baxter Human Albumin Injection Product and Services
2.4.4 Baxter Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Baxter Recent Developments/Updates
2.5 Kedrion Biopharma, Inc.
2.5.1 Kedrion Biopharma, Inc. Details
2.5.2 Kedrion Biopharma, Inc. Major Business
2.5.3 Kedrion Biopharma, Inc. Human Albumin Injection Product and Services
2.5.4 Kedrion Biopharma, Inc. Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Kedrion Biopharma, Inc. Recent Developments/Updates
2.6 Grifols
2.6.1 Grifols Details
2.6.2 Grifols Major Business
2.6.3 Grifols Human Albumin Injection Product and Services
2.6.4 Grifols Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Grifols Recent Developments/Updates
2.7 GE HealthCare
2.7.1 GE HealthCare Details
2.7.2 GE HealthCare Major Business
2.7.3 GE HealthCare Human Albumin Injection Product and Services
2.7.4 GE HealthCare Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 GE HealthCare Recent Developments/Updates
2.8 Bio Products Laboratory
2.8.1 Bio Products Laboratory Details
2.8.2 Bio Products Laboratory Major Business
2.8.3 Bio Products Laboratory Human Albumin Injection Product and Services
2.8.4 Bio Products Laboratory Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Bio Products Laboratory Recent Developments/Updates
2.9 Green Cross
2.9.1 Green Cross Details
2.9.2 Green Cross Major Business
2.9.3 Green Cross Human Albumin Injection Product and Services
2.9.4 Green Cross Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Green Cross Recent Developments/Updates
2.10 SK Plasma
2.10.1 SK Plasma Details
2.10.2 SK Plasma Major Business
2.10.3 SK Plasma Human Albumin Injection Product and Services
2.10.4 SK Plasma Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 SK Plasma Recent Developments/Updates
2.11 Instituto Grifols
2.11.1 Instituto Grifols Details
2.11.2 Instituto Grifols Major Business
2.11.3 Instituto Grifols Human Albumin Injection Product and Services
2.11.4 Instituto Grifols Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Instituto Grifols Recent Developments/Updates
2.12 Takeda
2.12.1 Takeda Details
2.12.2 Takeda Major Business
2.12.3 Takeda Human Albumin Injection Product and Services
2.12.4 Takeda Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Takeda Recent Developments/Updates
2.13 Hualan Bio
2.13.1 Hualan Bio Details
2.13.2 Hualan Bio Major Business
2.13.3 Hualan Bio Human Albumin Injection Product and Services
2.13.4 Hualan Bio Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Hualan Bio Recent Developments/Updates
2.14 Nanyue Biopharmaceuticals
2.14.1 Nanyue Biopharmaceuticals Details
2.14.2 Nanyue Biopharmaceuticals Major Business
2.14.3 Nanyue Biopharmaceuticals Human Albumin Injection Product and Services
2.14.4 Nanyue Biopharmaceuticals Human Albumin Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Nanyue Biopharmaceuticals Recent Developments/Updates
3 Competitive Environment: Human Albumin Injection by Manufacturer
3.1 Global Human Albumin Injection Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Albumin Injection Revenue by Manufacturer (2018-2023)
3.3 Global Human Albumin Injection Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Albumin Injection by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Albumin Injection Manufacturer Market Share in 2022
3.4.2 Top 6 Human Albumin Injection Manufacturer Market Share in 2022
3.5 Human Albumin Injection Market: Overall Company Footprint Analysis
3.5.1 Human Albumin Injection Market: Region Footprint
3.5.2 Human Albumin Injection Market: Company Product Type Footprint
3.5.3 Human Albumin Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Albumin Injection Market Size by Region
4.1.1 Global Human Albumin Injection Sales Quantity by Region (2018-2029)
4.1.2 Global Human Albumin Injection Consumption Value by Region (2018-2029)
4.1.3 Global Human Albumin Injection Average Price by Region (2018-2029)
4.2 North America Human Albumin Injection Consumption Value (2018-2029)
4.3 Europe Human Albumin Injection Consumption Value (2018-2029)
4.4 Asia-Pacific Human Albumin Injection Consumption Value (2018-2029)
4.5 South America Human Albumin Injection Consumption Value (2018-2029)
4.6 Middle East and Africa Human Albumin Injection Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Albumin Injection Sales Quantity by Type (2018-2029)
5.2 Global Human Albumin Injection Consumption Value by Type (2018-2029)
5.3 Global Human Albumin Injection Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Albumin Injection Sales Quantity by Application (2018-2029)
6.2 Global Human Albumin Injection Consumption Value by Application (2018-2029)
6.3 Global Human Albumin Injection Average Price by Application (2018-2029)
7 North America
7.1 North America Human Albumin Injection Sales Quantity by Type (2018-2029)
7.2 North America Human Albumin Injection Sales Quantity by Application (2018-2029)
7.3 North America Human Albumin Injection Market Size by Country
7.3.1 North America Human Albumin Injection Sales Quantity by Country (2018-2029)
7.3.2 North America Human Albumin Injection Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Albumin Injection Sales Quantity by Type (2018-2029)
8.2 Europe Human Albumin Injection Sales Quantity by Application (2018-2029)
8.3 Europe Human Albumin Injection Market Size by Country
8.3.1 Europe Human Albumin Injection Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Albumin Injection Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Albumin Injection Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Albumin Injection Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Albumin Injection Market Size by Region
9.3.1 Asia-Pacific Human Albumin Injection Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Albumin Injection Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Albumin Injection Sales Quantity by Type (2018-2029)
10.2 South America Human Albumin Injection Sales Quantity by Application (2018-2029)
10.3 South America Human Albumin Injection Market Size by Country
10.3.1 South America Human Albumin Injection Sales Quantity by Country (2018-2029)
10.3.2 South America Human Albumin Injection Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Albumin Injection Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Albumin Injection Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Albumin Injection Market Size by Country
11.3.1 Middle East & Africa Human Albumin Injection Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Albumin Injection Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Albumin Injection Market Drivers
12.2 Human Albumin Injection Market Restraints
12.3 Human Albumin Injection Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Albumin Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Albumin Injection
13.3 Human Albumin Injection Production Process
13.4 Human Albumin Injection Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Albumin Injection Typical Distributors
14.3 Human Albumin Injection Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer